High-Growth Healthcare Company Seeks NASDAQ Shell Acquisition

View Original Listing

Financial Details

Annual Revenue:
$65,000,000
Source:
Date:
June 17, 2025

Key Highlights

- Healthcare company with significant revenue ($65M run rate in 2025, projected $123M in 2026).
- Seeking to acquire a clean NASDAQ-listed public shell for direct transaction.
- Avoiding SPACs, OTCBB uplistings, and IPOs; willing to work with brokers and pay finder's fee.

Description

A healthcare company with a revenue run rate of $65 million in 2025, projected to reach $123 million by 2026, is seeking to acquire a clean NASDAQ-listed public shell for a direct transaction, avoiding SPACs, OTCBB uplistings, or IPOs. The company is willing to work with brokers and pay a finder's fee.

Industry Information

Industry Description:
Public Shells / Reverse Merger
Classification:
Financial Services

Listing Details

Listing ID:
ec212163-69b5-4e45-9574-5f5077a22fcd
Deal Status:
For Sale
Date Posted:
June 16, 2025
Last Updated:
June 17, 2025
Currency:
USD